ASCO President, 2010-2011: George W. Sledge, Jr, MD

Ballve-Lantero Professor of Oncology and Professor of Pathology and Laboratory Medicine at Indiana University Simon Cancer Center, George W. Sledge, Jr, MD, received his undergraduate degree from the University of Wisconsin and medical degree from Tulane University. He completed his residency at St. Louis University and fellowship at the University of Texas, San Antonio. Dr. Sledge has received the 2007 Jill Rose Award from the Breast Cancer Research Foundation and the 2006 Susan G. Komen Foundation Brinker Award for Scientific Distinction.

President-Elect: Michael P. Link, MD

Michael P. Link, MD, is the Lydia J. Lee Professor of Pediatric Cancer and Chief of the Division of Pediatric Hematology/Oncology at Stanford University School of Medicine, and Director of the Bass Center for Cancer and Blood Diseases at the Lucile Salter Packard Children's Hospital at Stanford. He received his medical degree from Stanford University. He completed an internship and residency in pediatrics at the Children's Hospital Medical Center in Boston, and fellowships in immunology and hematology/oncology at Children's Hospital Medical Center, the Dana-Farber Cancer Institute, and Harvard University.

Board of Directors

Community Oncologist: Robin T. Zon, MD, FACP

Vice President and Partner at Michiana Hematology-Oncology, PC, Medical Director for Oncology Research at Memorial Hospital of South Bend and Principal Investigator of the local Community Clinical Oncology Program (CCOP)/research consortium, Robin T. Zon, MD, obtained her medical degree at Indiana University School of Medicine. She completed her residency at St. Vincent Hospital and Health Care Center and her oncology/hematology fellowship at Indiana University. Dr. Zon worked as a pharmaceutical research investigator and manager of medical diagnostic product research and development at Boehringer Mannheim Diagnostic Company and the Merrell Dow Research Institute.

Medical Oncologist: James L. Abbruzzese, MD, FACP

James L. Abbruzzese, MD, is Professor of Medicine and Chair of the Department of Gastrointestinal Medical Oncology at The University of Texas M. D. Anderson Cancer Center, where he holds the M. G. and Lillie A. Johnson Chair for Cancer Treatment and Research. He completed his medical degree with honors from the University of Chicago. He completed his residency and a year of clinical fellowship in infectious diseases at the Johns Hopkins Hospital and a fellowship in medical oncology at Dana-Farber Cancer Institute.

Non-U.S. Oncologist: Frances A. Shepherd, MD, FRCPC

A Professor of Medicine at the University of Toronto, staff physician at the Princess Margaret Hospital of the University Health Network, and Scott Taylor Chair in Lung Cancer Research, France A. Shepherd, MD, received her medical degree from the University of Toronto and is a Fellow of the Royal College of Physicians and Surgeons of Canada in internal medicine and hematology. She was a rotating intern, junior assistant, and senior assistant at the Royal Victoria Hospital in Montreal. She also completed residencies at Mount Sinai Hospital and Toronto Western Hospital, and was a leukemia research fellow at Princess Margaret Hospital.

Radiation Oncologist: Lori J. Pierce, MD

A Professor in the Department of Radiation Oncology at the University of Michigan School of Medicine and Vice Provost for Academic & Faculty Affairs, Lori J. Pierce, MD, completed her medical degree at Duke University. She was medical intern at Thomas Jefferson University Hospital, and completed her residency at the Hospital of the University of Pennsylvania.

Undesignated Specialty: Julie M. Vose, MD

Julie M. Vose, MD, a Neumann M. and Mildred E. Harris Professor and Chief of the Section of Hematology/Oncology at the University of Nebraska Medical Center (UNMC), completed her internal medicine residency and hematology/oncology fellowship at the UNMC. She is currently enrolled in the Executive Program for Masters of Business Administration in Health Care Administration at the University of Colorado, Denver.

Nominating Committee

Howard A. Burris, III, MD, FACP

Howard A. Burris, III, MD, is Chief Medical Officer and Director of Drug Development at the Sarah Cannon Research Institute. A partner of Tennessee Oncology, PLLC, he completed his undergraduate studies at the U. S. Military Academy and obtained his medical degree at the University of South Alabama College of Medicine. He performed his internship, residency, and fellowship at Brooke Army Medical Center, San Antonio, Texas.

Roy S. Herbst, MD, PhD

A Professor in the Department of Thoracic/Head and Neck Medical Oncology, Chief of Thoracic Medical Oncology, Professor of Cancer Biology, and the Barnhart Family Distinguished Professor in Targeted Therapies at The University of Texas M. D. Anderson Cancer Center, Roy S. Herbst, MD, earned his doctorate in molecular cell biology at The Rockefeller University and medical degree from Cornell University Medical College. He completed his residency at Brigham and Women's Hospital and was Chief Resident at West Roxbury VA Hospital. He completed his medical oncology fellowship at Dana-Farber Cancer Institute and a hematology fellowship at Brigham and Women's Hospital. ■

© 2010. American Society of Clinical Oncology. All Rights Reserved.